Effect of disease progression on liver apparent diffusion coefficient values in a murine model of NASH at 11.7 Tesla

Stephan W Anderson1, Jorge A Soto, Holly N Milch

  • 1Boston University Medical Center, Department of Radiology, Boston, MA, USA. stephan.anderson@bmc.org

Abstract

Insights

Apparent diffusion coefficient (ADC) values decrease in the liver as non-alcoholic steatohepatitis (NASH) progresses. This finding, measured using high-field MRI in mice, shows a strong correlation between ADC and steatosis severity.

Area of Science:

  • Magnetic Resonance Imaging (MRI)
  • Hepatology
  • Medical Imaging

Background:

  • Non-alcoholic steatohepatitis (NASH) is a progressive liver disease.
  • Accurate non-invasive assessment of hepatic steatosis is crucial for diagnosis and management.
  • Diffusion-weighted MRI offers a potential method for evaluating liver tissue characteristics.

Purpose of the Study:

  • To investigate the relationship between apparent diffusion coefficient (ADC) values and the degree of steatosis in a murine model of NASH.
  • To evaluate the utility of 11.7 Tesla (T) MRI for assessing liver changes in NASH.

Main Methods:

  • A methionine-deficient choline-deficient (MCD) diet was used to induce NASH in 14 male C57BL/6 mice.
  • Control group consisted of 3 mice on a standard diet.
  • Ex vivo diffusion-weighted MRI was performed, and ADC maps were generated.
  • Steatosis was quantified using both subjective pathologist scores and digital image analysis (DIA).

Main Results:

  • ADC values were significantly lower in mice with NASH (mean 625 × 10⁻⁶ mm²/s) compared to controls (mean 786 × 10⁻⁶ mm²/s).
  • A strong negative correlation was observed between hepatic ADC values and the percentage of steatosis determined by DIA (R = -0.81, R = -0.91 with outlier exclusion).
  • Moderate correlation was found between ADC values and subjective steatosis scores (R = -0.56).

Conclusions:

  • Hepatic ADC values decrease with increasing severity of steatosis in NASH.
  • Diffusion-weighted MRI at 11.7T can effectively detect and quantify liver steatosis in a preclinical model.
  • ADC measurements show promise as a non-invasive biomarker for NASH.

Related Concept Videos